Click for best price
Human Microbiome Therapeutic Drugs Market Size, Share 2023
Human microbiome therapeutic drugs are drugs made by using the relationship between the gene content of the microbiota and metabolic activities.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Therapeutic Drugs. This report contains market size and forecasts of Human Microbiome Therapeutic Drugs in global, including the following market information:
Global Human Microbiome Therapeutic Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Human Microbiome Therapeutic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
FMT Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Microbiome Therapeutic Drugs include Rebiotix, Seres Therapeutics, Vedanta Biosciences, Bristol-Myers Squibb, Johnson and Johnson, Takeda and ENTEROME Bioscience, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Microbiome Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Microbiome Therapeutic Drugs Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Human Microbiome Therapeutic Drugs Market Segment Percentages, by Type, 2022 (%)
FMT
Microbiome Drugs
Others
Global Human Microbiome Therapeutic Drugs Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Human Microbiome Therapeutic Drugs Market Segment Percentages, by Application, 2022 (%)
Stomach
Oral
Respiratory Tract
Others
Global Human Microbiome Therapeutic Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Human Microbiome Therapeutic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Microbiome Therapeutic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Human Microbiome Therapeutic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson and Johnson
Takeda
ENTEROME Bioscience
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Microbiome Therapeutic Drugs, market overview.
Chapter 2: Global Human Microbiome Therapeutic Drugs market size in revenue.
Chapter 3: Detailed analysis of Human Microbiome Therapeutic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Microbiome Therapeutic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Human Microbiome Therapeutic Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Microbiome Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Microbiome Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Microbiome Therapeutic Drugs Overall Market Size
2.1 Global Human Microbiome Therapeutic Drugs Market Size: 2022 VS 2030
2.2 Global Human Microbiome Therapeutic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Microbiome Therapeutic Drugs Players in Global Market
3.2 Top Global Human Microbiome Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Human Microbiome Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Human Microbiome Therapeutic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Microbiome Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Microbiome Therapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Human Microbiome Therapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Microbiome Therapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Microbiome Therapeutic Drugs Market Size Markets, 2022 & 2030
4.1.2 FMT
4.1.3 Microbiome Drugs
4.1.4 Others
4.2 By Type - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global Human Microbiome Therapeutic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Human Microbiome Therapeutic Drugs Revenue, 2024-2030
4.2.3 By Type - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Microbiome Therapeutic Drugs Market Size, 2022 & 2030
5.1.2 Stomach
5.1.3 Oral
5.1.4 Respiratory Tract
5.1.5 Others
5.2 By Application - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global Human Microbiome Therapeutic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Human Microbiome Therapeutic Drugs Revenue, 2024-2030
5.2.3 By Application - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Human Microbiome Therapeutic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global Human Microbiome Therapeutic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Human Microbiome Therapeutic Drugs Revenue, 2024-2030
6.2.3 By Region - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Human Microbiome Therapeutic Drugs Revenue, 2018-2030
6.3.2 US Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.3.3 Canada Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.3.4 Mexico Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Human Microbiome Therapeutic Drugs Revenue, 2018-2030
6.4.2 Germany Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.4.3 France Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.4.4 U.K. Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.4.5 Italy Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.4.6 Russia Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.4.8 Benelux Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Human Microbiome Therapeutic Drugs Revenue, 2018-2030
6.5.2 China Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.5.3 Japan Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.5.4 South Korea Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.5.6 India Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Human Microbiome Therapeutic Drugs Revenue, 2018-2030
6.6.2 Brazil Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.6.3 Argentina Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue, 2018-2030
6.7.2 Turkey Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.7.3 Israel Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Human Microbiome Therapeutic Drugs Market Size, 2018-2030
6.7.5 UAE Human Microbiome Therapeutic Drugs Market Size, 2018-2030
7 Human Microbiome Therapeutic Drugs Companies Profiles
7.1 Rebiotix
7.1.1 Rebiotix Company Summary
7.1.2 Rebiotix Business Overview
7.1.3 Rebiotix Human Microbiome Therapeutic Drugs Major Product Offerings
7.1.4 Rebiotix Human Microbiome Therapeutic Drugs Revenue in Global Market (2018-2023)
7.1.5 Rebiotix Key News & Latest Developments
7.2 Seres Therapeutics
7.2.1 Seres Therapeutics Company Summary
7.2.2 Seres Therapeutics Business Overview
7.2.3 Seres Therapeutics Human Microbiome Therapeutic Drugs Major Product Offerings
7.2.4 Seres Therapeutics Human Microbiome Therapeutic Drugs Revenue in Global Market (2018-2023)
7.2.5 Seres Therapeutics Key News & Latest Developments
7.3 Vedanta Biosciences
7.3.1 Vedanta Biosciences Company Summary
7.3.2 Vedanta Biosciences Business Overview
7.3.3 Vedanta Biosciences Human Microbiome Therapeutic Drugs Major Product Offerings
7.3.4 Vedanta Biosciences Human Microbiome Therapeutic Drugs Revenue in Global Market (2018-2023)
7.3.5 Vedanta Biosciences Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Major Product Offerings
7.4.4 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Johnson and Johnson
7.5.1 Johnson and Johnson Company Summary
7.5.2 Johnson and Johnson Business Overview
7.5.3 Johnson and Johnson Human Microbiome Therapeutic Drugs Major Product Offerings
7.5.4 Johnson and Johnson Human Microbiome Therapeutic Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson and Johnson Key News & Latest Developments
7.6 Takeda
7.6.1 Takeda Company Summary
7.6.2 Takeda Business Overview
7.6.3 Takeda Human Microbiome Therapeutic Drugs Major Product Offerings
7.6.4 Takeda Human Microbiome Therapeutic Drugs Revenue in Global Market (2018-2023)
7.6.5 Takeda Key News & Latest Developments
7.7 ENTEROME Bioscience
7.7.1 ENTEROME Bioscience Company Summary
7.7.2 ENTEROME Bioscience Business Overview
7.7.3 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Major Product Offerings
7.7.4 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Revenue in Global Market (2018-2023)
7.7.5 ENTEROME Bioscience Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Human Microbiome Therapeutic Drugs Market Opportunities & Trends in Global Market
Table 2. Human Microbiome Therapeutic Drugs Market Drivers in Global Market
Table 3. Human Microbiome Therapeutic Drugs Market Restraints in Global Market
Table 4. Key Players of Human Microbiome Therapeutic Drugs in Global Market
Table 5. Top Human Microbiome Therapeutic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Microbiome Therapeutic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Microbiome Therapeutic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Microbiome Therapeutic Drugs Product Type
Table 9. List of Global Tier 1 Human Microbiome Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Microbiome Therapeutic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Human Microbiome Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Microbiome Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Human Microbiome Therapeutic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Microbiome Therapeutic Drugs Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Human Microbiome Therapeutic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Microbiome Therapeutic Drugs Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2024-2030
Table 30. Rebiotix Company Summary
Table 31. Rebiotix Human Microbiome Therapeutic Drugs Product Offerings
Table 32. Rebiotix Human Microbiome Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Rebiotix Key News & Latest Developments
Table 34. Seres Therapeutics Company Summary
Table 35. Seres Therapeutics Human Microbiome Therapeutic Drugs Product Offerings
Table 36. Seres Therapeutics Human Microbiome Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Seres Therapeutics Key News & Latest Developments
Table 38. Vedanta Biosciences Company Summary
Table 39. Vedanta Biosciences Human Microbiome Therapeutic Drugs Product Offerings
Table 40. Vedanta Biosciences Human Microbiome Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Vedanta Biosciences Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Product Offerings
Table 44. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Johnson and Johnson Company Summary
Table 47. Johnson and Johnson Human Microbiome Therapeutic Drugs Product Offerings
Table 48. Johnson and Johnson Human Microbiome Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson and Johnson Key News & Latest Developments
Table 50. Takeda Company Summary
Table 51. Takeda Human Microbiome Therapeutic Drugs Product Offerings
Table 52. Takeda Human Microbiome Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Takeda Key News & Latest Developments
Table 54. ENTEROME Bioscience Company Summary
Table 55. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Product Offerings
Table 56. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. ENTEROME Bioscience Key News & Latest Developments
List of Figures
Figure 1. Human Microbiome Therapeutic Drugs Segment by Type in 2022
Figure 2. Human Microbiome Therapeutic Drugs Segment by Application in 2022
Figure 3. Global Human Microbiome Therapeutic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Microbiome Therapeutic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Human Microbiome Therapeutic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Microbiome Therapeutic Drugs Revenue in 2022
Figure 8. By Type - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 10. By Type - Global Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 12. By Application - Global Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 14. By Region - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 15. By Country - North America Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 16. US Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 20. Germany Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. France Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 28. China Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. India Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 34. Brazil Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue Market Share, 2018-2030
Figure 37. Turkey Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Human Microbiome Therapeutic Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. Rebiotix Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Seres Therapeutics Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Vedanta Biosciences Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson and Johnson Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Takeda Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
